Benzylamine hydrochloride - CAS 3287-99-8
Catalog: |
BB021455 |
Product Name: |
Benzylamine hydrochloride |
CAS: |
3287-99-8 |
Synonyms: |
phenylmethanamine;hydrochloride |
IUPAC Name: | phenylmethanamine;hydrochloride |
Description: | Benzylamine hydrochloride is a natural compound isolated from the herbs of Moringa oleifera. |
Molecular Weight: | 143.61 |
Molecular Formula: | C7H10ClN |
Canonical SMILES: | C1=CC=C(C=C1)CN.Cl |
InChI: | InChI=1S/C7H9N.ClH/c8-6-7-4-2-1-3-5-7;/h1-5H,6,8H2;1H |
InChI Key: | XKXHCNPAFAXVRZ-UHFFFAOYSA-N |
Boiling Point: | 185 °C at 760 mmHg |
Melting Point: | 253 °C |
Purity: | > 98.0 % (T) (HPLC) |
Solubility: | >21.5 [ug/mL] (The mean of the results at pH 7.4) |
Appearance: | Powder |
Storage: | Store under inert gas |
MDL: | MFCD00012852 |
LogP: | 2.64760 |
Vapor Pressure: | 0.00000172 [mmHg] |
GHS Hazard Statement: | H302 (95.65%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
US-10799530-B1 | Composition and method for the prevention and treatment of obesity | 20191220 |
US-10933091-B1 | Composition and method for the treatment of type I diabetes | 20191220 |
US-2021187015-A1 | Composition and method for the prevention and treatment of type 2 diabetes | 20191220 |
US-2021187016-A1 | Method of treating nonalcoholic steatohepatitis | 20191220 |
US-2021187017-A1 | Composition and method for the prevention and treatment of obesity | 20191220 |
PMID | Publication Date | Title | Journal |
31153898 | 20190901 | Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of dextromethorphan in hearing loss rat model | Toxicology and applied pharmacology |
27074625 | 20160526 | Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer | Journal of medicinal chemistry |
24064863 | 20131114 | Enantioselective synthesis of encecaline-derived potent antimalarial agents | Organic & biomolecular chemistry |
23018155 | 20121105 | A seven-coordinated manganese(II) complex with V-shaped ligand bis(N-benzylbenzimidazol-2-ylmethyl)benzylamine: synthesis, structure, DNA-binding properties and antioxidant activities | Journal of photochemistry and photobiology. B, Biology |
22944335 | 20121001 | O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation | Bioorganic & medicinal chemistry |
Complexity: | 55.4 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 143.0501770 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 143.0501770 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS